Hit the road Jack! W. FRANK PEACOCK, MD, FACEP, FACC

Similar documents
9/11/2017. Hit the road Jack! A review of ADPs (Accelerated Diagnostic Protocols) 2017 COI Disclosures: W. Frank Peacock, MD, FACEP,FACC.

High-Sensitivity Cardiac Troponin in Suspected ACS

Dolore Toracico e Livelli di Troponina non Misurabili

High Sensitivity Troponin Improves Management. But Not Yet

Mario Plebani University-Hospital of Padova, Italy

Rapid Disposition of Chest Pain Patients February 2019

BioRemarkable Symposium

Troponin when is an assay high sensitive?

. θωρακικούάλγουςστα εξωτερικά ιατρεία

Congreso Nacional del Laboratorio Clínico 2016

Troponin = 35. Objectives. Low Risk Chest Pain. Does this patient have ACS? Does this patient have ACS? Objectives

Defining rise and fall of cardiac troponin values

Bertil Lindahl Akademiska sjukhuset Uppsala

How will new high sensitive troponins affect the criteria?

Use of Biomarkers for Detection of Acute Myocardial Infarction

10 Ways to Make the Use of High Sensitivity Cardiac Troponin Values Easier and Better

Peri-operative Troponin Measurements - Pathophysiology and Prognosis

Troponin Assessment. Does it Carry Clinical Message? Stefan Blankenberg. University Heart Center Hamburg

Low Risk Chest Pain. Objectives. Disclosure. Case 1. Jeffrey Tabas, MD Professor of Emergency Medicine Office of CME UCSF School of Medicine

Waiting for High-Sensitivity POCT Cardiac Troponin Assays: Clinical and Analytical Needs I Have a Pain in My Chest That Hurts Very Bad

DIFFERENTIATING THE PATIENT WITH UNDIFFERENTIATED CHEST PAIN

Recognizing the High Risk NSTEMI Patient for Early Appropriate Therapy

Acute Coronary Syndrome. Sonny Achtchi, DO

High Sensitivity Troponins. IT S TIME TO SAVE LIVES. Updates from the ESC 2015 Guidelines November 17th 2016 OPL CONGRESS Dr.

Better, higher, lower, faster: increasingly rapid clinical decision making using high-sensitivity cardiac troponin assays

Impact of Troponin Performance on Patient Care

Acute Coronary Syndrome. Cindy Baker, MD FACC Director Peripheral Vascular Interventions Division of Cardiovascular Medicine

Measuring Natriuretic Peptides in Acute Coronary Syndromes

Undetectable High Sensitivity Cardiac Troponin T Level in the Emergency Department and Risk of Myocardial Infarction

Non ST Elevation-ACS. Michael W. Cammarata, MD

7/31/2018. Overview of Next Generation Cardiac Troponin T High Sensitivity. Disclosures. Course Objectives: high sensitive Troponin T assay

Chest pain and troponins on the acute take. J N Townend Queen Elizabeth Hospital Birmingham

Novel Risk Markers in ACS (Hyperglycemia, Anemia, GFR)

CLINICAL GUIDANCE FRAMEWORKS

Current and Future Imaging Trends in Risk Stratification for CAD

CARDIOLOGY GRAND ROUNDS

Essam Mahfouz, MD. Professor of Cardiology, Mansoura University

Fifty shades of Troponin. Dr Liam Penny The Queens Hotel, Cheltenham 4 th October 2012

Low concentrations of high-sensitivity troponin T at presentation to the

hs-c Tn I high sensitivity troponin I <17 min

Why and How Should We Switch Clopidogrel to Prasugrel?

Post-Procedural Myocardial Injury or Infarction

Culprit PCI vs MultiVessel PCI for Acute Myocardial Infarction

Current Utilities of Cardiac Biomarker Testing at POC. June 24, 2010 Joe Pezzuto, MT (ASCP) Carolyn Kite, RN

New diagnostic markers for acute coronary syndromes

ACCESS hstni SCIENTIFIC LITERATURE

M/39 CC D. => peak CKMB (12 hr later) ng/ml T.chol/TG/HDL/LDL 180/150/48/102 mg/dl #

Disclosures. Inpatient Management of Non-ST Elevation Acute Coronary Syndromes. Edward McNulty MD, FACC. None

OVERVIEW ACUTE CORONARY SYNDROME SYMPTOMS 9/30/14 TYPICAL WHAT IS ACUTE CORONARY SYNDROME? SYMPTOMS, IDENTIFICATION, MANAGEMENT

Chest Pain Wave I Webinar. May, 30 th 2017

EARLY DIAGNOSIS AND RISK STRATIFICATION IN PATIENTS WITH SYMPTOMS SUGGESTIVE OF ACUTE CORONARY SYNDROME

Acute Coronary Syndrome

Belinda Green, Cardiologist, SDHB, 2016

Risk Stratification of ACS Patients. Frans Van de Werf, MD, PhD University of Leuven, Belgium

The PAIN Pathway for the Management of Acute Coronary Syndrome

Management of ST-elevation myocardial infarction Update 2009 Late comers: which options?

Upstream P2Y 12 RB. Stefano Savonitto Divisione di Cardiologia Arcispedale S. Maria Nuova Reggio Emilia

The patient with 30 min chest pain presenting at the ER two hours after onset of symptoms. Professor Christian Mueller

The clinical performance of the novel POC Minicare ctni-assay. Per Venge, MD PhD Professor in Clinical Chemistry Uppsala University Uppsala, Sweden

Platelet function testing to guide P2Y 12 -inhibitor treatment in ACS patients after PCI: insights from a national program in Hungary

International Journal of Cardiology and Cardiovascular Research Vol. 4(2), pp , September, ISSN:

Undetectable High Sensitivity Cardiac Troponin T Level in the Emergency Department and Risk of Myocardial Infarction

Cardiac Troponin Testing and Chest Pain Patients: Exploring the Shades of Gray

When Telemedicine meet Acute Chest Pain Patients How we use in-hospital tele-ecg to improved quality of care and improved D2BT of STEMI patients

Objectives. Identify early signs and symptoms of Acute Coronary Syndrome Initiate proper protocol for ACS patient 10/2013 2

Clinical Seminar. Which Diabetic Patient is a Candidate for Percutaneous Coronary Intervention - European Perspective

CHEST PAIN CDU INCLUSION CRITERIA

Ticagrelor compared with clopidogrel in patients with acute coronary syndromes the PLATO trial

Prasugrel vs. Ticagrelor in ACS/PCI Which one to choose? V. Voudris MD FESC FACC 2 nd Cardiology Division Onassis Cardiac Surgery Center

The Clinical Value of Cardiac Biomarkers in the Management of Acute Coronary Syndrome And Heart Failure

Topic. Updates on Definition of Myocardial Infarction

TOPICS IN EMERGENCY MEDICINE SEMI-FINAL

Does serial troponin measurement help identify acute ischemia/ischemic events?

Quale terapia antiaggregante nello STEMI? Prasugrel vs ticagrelor

Chest Pain. Dr Robert Huggett Consultant Cardiologist

David A. Orsinelli, MD, FACC, FASE Professor, Internal Medicine The Ohio State University Division of Cardiovascular Medicine Columbus, Ohio

Improving STEMI outcomes in Denmark. Michael Rahbek Schmidt, MD, PhD. Aarhus University Hospital Skejby Denmark

Chest Pain 101: Fine Tuning Your Differential in the Outpatient Setting. Krysten Pilkington MNSc, APRN, AG-ACNP-BC

What have We Learned in Dyslipidemia Management Since the Publication of the 2013 ACC/AHA Guideline?

The Clinical Laboratory Working with Physicians to Improve Patient Care

Case Presentation. Rafael Bitzur The Bert W Strassburger Lipid Center Sheba Medical Center Tel Hashomer

Simon A. Mahler MD, MS, FACEP Associate Professor Department of Emergency Medicine Wake Forest School of Medicine

Biomarkers Now and in the Future of Emergency Medicine- TIME TO USE sst2 Alan S. Maisel MD FACC Professor of Medicine, Emeritus University of

Surgical vs. Percutaneous Revascularization in Patients with Diabetes and Acute Coronary Syndrome

12/18/2009 Resting and Maxi Resting and Max mal Coronary Blood Flow 2

Using DOACs in CAD Patients in Sinus Ryhthm Results of the ATLAS ACS 2, COMPASS and COMMANDER-HF Trials

REFERRAL HOSPITAL. The Importance of Door In Door Out Time DIDO

Rapid rule out of acute myocardial infarction: novel biomarker-based strategies

FFR-guided Complete vs. Culprit Only Revascularization in AMI Patients Ki Hong Choi, MD On Behalf of FRAME-AMI Investigators

TROPONIN POSITIVE 2/20/2015 WHAT DOES IT MEAN? When should a troponin level be obtained?

Percutaneous Coronary Interventions Without On-site Cardiac Surgery

Clinical Controversies in Perioperative Medicine

Overcoming the Risk-Treatment Paradox in Non-STE ACS: It s Time! Christopher Granger, MD

Recent community campaigns on

What oral antiplatelet therapy would you choose? a) ASA alone b) ASA + Clopidogrel c) ASA + Prasugrel d) ASA + Ticagrelor

The 2016 NASCI Keynote: Trends in Utilization of Cardiac Imaging: The Coronary CTA Conundrum. David C. Levin, M.D.

Adults With Diagnosed Diabetes

Hospital-Acquired Anemia: Epidemiology, Prevention and Management in Patients with Acute Coronary Syndromes

Validation of an accelerated high-sensitivity troponin T assay protocol in an Australian cohort with chest pain

DIAGNOSTICS ASSESSMENT PROGRAMME

Transcription:

Hit the road Jack! W. FRANK PEACOCK, MD, FACEP, FACC

Visits 130,000,000 annually 10.4 M chest pain (8.0%) 4.1 M sent home non-cardiac 6.24 M suspected or actual cardiac 50,000 MIs 3.1 M non-cardiac (50%) 1.2 M AMI (20%) 1.5 M UA (24%) 374,400 sudden death (6%)

Musculoskeletal Pain Blunt Chest Trauma Mediastinitis IVDA Pulm Infarction Anxiety Pulmonary Embolus Panic Attack Breast Abcess Aortic Dissection Pneumothorax Empyema Pneumonia Breast Implant Tietze s disease Mondor s Syndrome Thoracic Spine Ds GERD Asthma Herpes Zoster Contact Dermatitis Breast Cancer Mallory- Weiss Subdiaphrag Abcess Sickle cell Anemia Lung Cancer Amniotic Fluid Embolus Myocardial Pain Boerhave s

Hs Tn (STATISTICAL) Definition You can t have it both ways Sensitivity Specificity TP/(TP+FN) TN/(TN+FP)

How often is the EKG diagnostic? 2% 10.4 million annual ER CP STEMI = 208,000 3500 ER s = 59 STEMI/ER/yr No ECG = 10,192,000/yr = 2,912/ER/yr = to find 59 N=10,869 Pope JH, et al. Missed Diagnosis of Acute Cardiac Ischemia in the ED, NEJM 2000;342:1163-70

How good are the parts? Than M. Lancet, 2011. DOI:10.1016/S0140-6736(11)60310-3 Sensitivity NPV ECG 35.2 89.3 POC markers 82.9 96.1 TIMI 96.7 97.5 POC + ECG 88.8 96.7 TIMI + ECG 98.1 98.3 ADP 99.3 99.1

How often is the Tn diagnostic? 8% 10.4 million annual ER CP Total NSTEMI = 822,000 3500 USA ER s = 238/ER/yr 9,568,000 Tn/yr 2733 -Tn/ER to find 238 N=10,869 Pope JH, et al. Missed Diagnosis of Acute Cardiac Ischemia in the ED NEJM 2000;342:1163-70

What is the fastest troponin? POC vs the central lab. 5 hospitals 4609 Tn POC samples 3447 split and sent to lab for CKMB Locale Hosp Type Transp POC Tn ED Univ Pneumo tube ED Univ Courier 22±0.5 (n=855) 21±0.2 (n=1879) CCU Rural Nurses 12±0.5 (n=471) ED Muni Pneumo 22±0.8 (n=706) tube ED Univ Pneumo 18±0.5 tube (n=698) All 20±0.2 (n=4609) CL CKMB 107±2.3 (n=1744) 72±1.7 (n=689) 147±64.1 (n=150) 90±0.5 (n=185) 52±1.4 (n=679) 85±1.5 (n=3447) Diff (mins) 86±2.3 50±1.5 135±64.1 68±1.1 34±1.4 65±1.5 Gaze D et al. Point of Care: The Journal of Near-Patient Testing & Technology. 2004;3:156 158.

How good are the parts? Than M. Lancet, 2011. DOI:10.1016/S0140-6736(11)60310-3 Sensitivity NPV ECG 35.2 89.3 POC markers 82.9 96.1 TIMI 96.7 97.5 POC + ECG 88.8 96.7 TIMI + ECG 98.1 98.3 ADP 99.3 99.1

How sensitive does it have to be? 100,000 Annual ER visits 8% CP = 8k/yr = 22/day Sn = 95% Miss 5 out of 100 Miss 1 AMI every 4.5 days Miss 81 AMI/yr Sn=99.5% Miss 1 out of 200 Miss 1 every 9 days

OK it has to go to the lab, but how about one and done???

Why isn t 1 troponin enough? ADAPT and APACE had presentations at ~4 hours. Your cutpoint is? Lets say 13 pg/ml Mrs Jones normally lives at 4 She presents 45 minutes after CP onset Tn is 12 (300% increase from baseline)

Meta analysis of 23 papers Elecsys hs TnT at ED presentation LOD=5 ng/l, LOQ=13 ng/l (the lowest TnT that has CV of 10%) 99th %ile of healthy pop =14 ng/l Results N=9428 Pre-test probability of AMI 21% Most patients presented within 12 hrs of symptom onset study medians 3.5-6.3 hrs One and done? Using 14 ng/l cutpoint Sn= 89.5% (95% CI 86.3% to 92.1%), Sp=77.1% (68.7% to 83.7%). Cutpoints determine miss rate For 100 consecutive patients 5 ng/l will miss 2-3 AMI 3 ng/l will miss 0 AMI BMJ

718 consecutive ED suspect AMI MI/USA 238 (33.1%) Reichlin T. N Engl J Med 2009;361:858-67.

Chest Pain Protocol VS. ADP A CHEST PAIN PROTOCOL A series of activities to identify a patient as: 1) Having an event 2) Being at risk for having an event AN ACCELERATED DIAGNOSTIC PROTOCOL A series of activities to identify the patient as: 1) NOT having an event 2) Being at low risk for having an event

Why an ADP? Accelerated Diagnostic Protocol Reason for an ADP ER docs vs risk scores Docs are risk adverse Docs always admit more than scores

Why do we admit sooo many? ER Dr. LAWYER

ADP is for discharging! Maybe that is a good idea? Risk Scores ADP 1) Non-Dx ECG 2) (-) Tn x2 3) Low Risk Score TIMI HEART EDACS CRUSADE GRACE

TIMI Risk Score: 2 week MACE Risk factors: Age 65 years 3 risk factors for CAD Prior coronary stenosis 50% ST-segment deviation on ECG 2 anginal events in last 24 hours Use of ASA in last 7 days Elevated serum cardiac markers CK-MB or troponin Rate of Composite Endpoint (Days 1-14), % 45 40 35 30 25 20 15 10 5 0 40.9 26.2 19.9 13.2 8.3 4.7 0/1 2 3 4 5 6/7 Number of Risk Factors 1 Each risk factor is = 1 point, and total represents TIMI Risk Score Event rates (all-cause mortality, MI, or UTVR) increase with each 1-point increase in score Antman EM et al. JAMA. 2000;284:835-842.

How good are the parts? Than M. Lancet, 2011. DOI:10.1016/S0140-6736(11)60310-3 Sensitivity NPV ECG 35.2 89.3 POC markers 82.9 96.1 TIMI 96.7 97.5 POC + ECG 88.8 96.7 TIMI + ECG 98.1 98.3 ADP 99.3 99.1

HEART Score for 6 week MACE MACE = AMI, PCI, CABG, (+) cath, death Hx: Hi =2, Mod =1, Slight =0 ECG: Sig ST dep =2, NS repol =1, Nl =0 Age: 65 =2, 45-65 =1, 45 =0 Risks: 3 =2, 1-2 =1, 0=0 RISKS Hyperchole, HTN, DM Tobbacco (+) FH, Obesity Tn: 3x ULN =2 1-3 ULN =1 ULN =0 Low risk = 0-3; <2% MACE risk

HEART Pathway Randomized Trial 282 ED suspected ACS patients, randomized to HEART or standard tx HEART N=141, with score < 4, negative Tn at 0 and 3 hours 75 low risk, 56 discharged Standard care N=141, per ACC/AHA guidelines X low risk, 26 discharged. Results: No MACE in either arm HEART lower objective cardiac testing; 68.8 vs 56.7% (P=0.048) lower LOS; 9.9 vs 21.9 hours (P=0.013) higher early discharges by 21.3% (39.7% versus 18.4%; P<0.001). Mahler S. Circ Cardiovasc Qual Outcomes. 2015 March ; 8(2): 195 203

EDACS-ADP Emergency Department Assessment Chest Pain Score - Accelerated Diagnostic Procedure Characteristic Parameter Points History 18-50 yo with CAD, or >2 risk factors +4 Age 18-45 +2 46-50 +4 51-55 +6 56-60 +8 61-65 +10 66-70 +12 71-75 +14 76-80 +16 81-85 +18 >85 +20 Characteristic Parameter Points Sex Male +6 Signs and Symptoms Diaphoresis +3 Arm or shoulder radiation Pain occurred or worsened with inspiration Pain is reproduced with palpation +5-4 -6 Low Risk Criteria EDACS Score <16 No new ECG ischemia Negative 0 and 2h Tn

PEARL Comparing Scores EDACS HEART-2 PEARL data set: 7 Eds N=458 Patient with suspected ACS HEART -1 TIMI GRACE Dr documented risk of MI before Tn results as Low, Moderate, or High Singer A. Am JEM, 2017, Jan 5. pii: S0735-6757(17)30003-7. doi: 10.1016/j.ajem.2017.01.003. [Epub ahead of print]

Scores: standard cutpoint Low risk definition N % with AMI Sensitivity Clinical Low 136 5.9 (3.0-11.2) 88.7 (78.5-94.7) HEART 0-3 146 4.1 (1.9-8.7) 91.5 (81.9-96.5) TIMI 0 26 0 (0-12.9) 100 (93.6-100) GRACE <51 14 7.1 (1.3-31.5) 98.6 (91.4-99.9) EDACS <16 195 1.0 (0.2-4.1) 97.1 (89.1-99.5) Singer A. Am J EM. 2017 Jan 5. pii: S0735-6757(17)30003-7. doi: 10.1016/j.ajem.2017.01.003.

Performance: Sensitivity set at 99% Sensitivity set at 99% Cutoff % Low Risk Clinical -- -- HEART-1 0 1 HEART-2 0-2 18.9 TIMI 0 7 GRACE 49 3.2 EDACS 12 34.3 Singer A. Am J EM. 2017 Jan 5. pii: S0735-6757(17)30003-7. doi: 10.1016/j.ajem.2017.01.003.

How many will the ADP D/C? 10.4 million annual ER CP 3500 USA ER s ED D/C rate # of patients 7.0 (TIMI) 728,000 18.9 (HEART) 1,965,600 34.3 (EDACS) 3,567,200 77% (TRAPID) 8,008,000

High Sensitivity Troponin in the USA FDA clears blood test to help diagnose patients with a suspected MI Jan 19, 2017 The FDA granted a 510(k) clearance for the Elecsys Troponin T Gen 5 STAT blood test for patients with a suspected MI.

Increased Troponin Sensitivity = More ED Discharges Patients Discharged Early (%) 70 60 50 40 30 20 10 0 9.8 ASPECT 1 ctni 50 ng/l 20.0 ADAPT 2 ctni 30 ng/l 38.6 APACE 3 ctni 26.2 ng/l 63.4 TRAPID-AMI 4 ctnt 12 ng/l; Δ1 hour 3 ng/l 1) Than M, Cullen L, Reid C, et al. Lancet. 2011;377:1077-84. 2) Than M, Cullen L, Aldous S, et al. J Am Coll Cardiol. 2012;59(23):2091-8. 3) Cullen L, Mueller C, Parsonage WA, et al. J am Coll Cardiol. 2013;62(14):1242-9. 4) Mueller C, Giannitsis E, Christ M, et al. Ann Emerg Med. 2016;68(1):76-87.

2015 ESC Guidelines The NPV for MI in patients assigned rule-out exceeded 98% in several large validation cohorts Eur Heart J. 2016 Jan 14;37(3):267-315.

Will the ESC guidelines work in the US? hsctnt and I at 0 and 3 h postpresentation Purpose: validate the ESC Working Group on Acute Cardiac Care rule-in algorithm 1061 hstni 985 hstnt Sn of 99th %ile to R/O AMI HsTnI 93.2% HsTnT 94.8% Pickering JW, et al. Heart 2016;0:1 9.

How quickly can I make a decision? ECG 10 Tn (central lab) 90 Risk Score (EDACS) Some admitted Repeat Tn @ 3 hrs Returns for decision. ~4 hours